InvestorsHub Logo

exwannabe

09/11/15 8:50 PM

#14546 RE: JLS #14544

Re: Scripts.

Agreed that the numbers basically suck (to use a highly technical term).

The refill number still looks like at best a 30% take rate (30% of those who try the product stick with it). And this is within users who are likely ideal candidates.

I still believe that this product could "work", but hard to see establishing a position in MNKD until these numbers start to look significantly better.

robert sacher

09/12/15 8:34 AM

#14550 RE: JLS #14544

For folks who are tracking prescription data:

Week ending 8/28/2015
NRx: 302
NRx$: 188,176.60
TRx: 511
TRx$: 280,200.50

Week ending 9/4/2015
NRx: 353
NRx$: 167,682.60
TRx: 585
TRx$: 270,808.30

New prescriptions up 17%.
TRx prescriptions up 14.5%.

Afrezza hit a new record for TRx this week (585, taking out the last high of 529 reached for the week of 8/21/2015).

All in all, it was a pretty good week.

Read more: http://bit.ly/1FCcUXE